Small-molecule inhibitors of setd8 with cellular activity

ACS Chemical Biology

Volumn 9, Issue 11, 2014, Pages 2471-2478

  Blum, Gil ^a   Ibáñez, Glorymar ^a   Rao, Xiangjun ^b   Shum, David ^a   Radu, Constantin ^a   Djaballah, Hakim ^a   Rice, Judd C ^b   Luo, Minkui ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BVT 948; HISTONE LYSINE METHYLTRANSFERASE; HISTONE LYSINE METHYLTRANSFERASE INHIBITOR; LYSINE; METHYLTRANSFERASE; NSC 663284; PROTEIN INHIBITOR; RYUVIDINE; UNCLASSIFIED DRUG; SETD8 PROTEIN, HUMAN;

ARTICLE; CELL ACTIVITY; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; DNA DAMAGE; DNA REPLICATION; DRUG STRUCTURE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IC50; IN VIVO STUDY; PROTEIN MOTIF; RNA INTERFERENCE; VALIDATION STUDY; ANTAGONISTS AND INHIBITORS; HEK293 CELL LINE;

HEK293 CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS;

EID: 84914140052     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb500515r     Document Type: Article

References (41)

1. Kouzarides, T. (2007) Chromatin modifications and their function Cell 128, 693-705
2. Luo, M. (2012) Current chemical biology approaches to interrogate protein methyltransferases ACS Chem. Biol. 7, 443-463
3. Nishioka, K., Rice, J. C., Sarma, K., Erdjument-Bromage, H., Werner, J., Wang, Y., Chuikov, S., Valenzuela, P., Tempst, P., Steward, R., Lis, J. T., Allis, C. D., and Reinberg, D. (2002) PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin Mol. Cell 9, 1201-1213
4. Wu, S. and Rice, J. C. (2011) A new regulator of the cell cycle: the PR-Set7 histone methyltransferase Cell Cycle 10, 68-72
5. Jorgensen, S., Eskildsen, M., Fugger, K., Hansen, L., Larsen, M. S., Kousholt, A. N., Syljuasen, R. G., Trelle, M. B., Jensen, O. N., Helin, K., and Sorensen, C. S. (2011) SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation J. Cell. Biol. 192, 43-54
6. Centore, R. C., Havens, C. G., Manning, A. L., Li, J. M., Flynn, R. L., Tse, A., Jin, J., Dyson, N. J., Walter, J. C., and Zou, L. (2010) CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase Mol. Cell 40, 22-33
7. Oda, H., Hubner, M. R., Beck, D. B., Vermeulen, M., Hurwitz, J., Spector, D. L., and Reinberg, D. (2010) Regulation of the histone H4 monomethylase PR-Set7 by CRL4(Cdt2)-mediated PCNA-dependent degradation during DNA damage Mol. Cell 40, 364-376
8. Wu, S., Wang, W., Kong, X., Congdon, L. M., Yokomori, K., Kirschner, M. W., and Rice, J. C. (2010) Dynamic regulation of the PR-Set7 histone methyltransferase is required for normal cell cycle progression Genes Dev. 24, 2531-2542
9. Abbas, T., Shibata, E., Park, J., Jha, S., Karnani, N., and Dutta, A. (2010) CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation Mol. Cell 40, 9-21
10. Huen, M. S., Sy, S. M., van Deursen, J. M., and Chen, J. (2008) Direct interaction between SET8 and proliferating cell nuclear antigen couples H4-K20 methylation with DNA replication J. Biol. Chem. 283, 11073-11077
11. Houston, S. I., McManus, K. J., Adams, M. M., Sims, J. K., Carpenter, P. B., Hendzel, M. J., and Rice, J. C. (2008) Catalytic function of the PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability J. Biol. Chem. 283, 19478-19488
12. Tardat, M., Brustel, J., Kirsh, O., Lefevbre, C., Callanan, M., Sardet, C., and Julien, E. (2010) The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells Nat. Cell Biol. 12, 1086-1093
13. Jorgensen, S., Schotta, G., and Sorensen, C. S. (2013) Histone H4 lysine 20 methylation: key player in epigenetic regulation of genomic integrity Nucleic Acids Res. 41, 2797-2806
14. Shi, X., Kachirskaia, I., Yamaguchi, H., West, L. E., Wen, H., Wang, E. W., Dutta, S., Appella, E., and Gozani, O. (2007) Modulation of p53 function by SET8-mediated methylation at lysine 382 Mol. Cell 27, 636-646
15. Dhami, G. K., Liu, H., Galka, M., Voss, C., Wei, R., Muranko, K., Kaneko, T., Cregan, S. P., Li, L., and Li, S. S. (2013) Dynamic methylation of Numb by Set8 regulates its binding to p53 and apoptosis Mol. Cell 50, 565-576
16. Takawa, M., Cho, H. S., Hayami, S., Toyokawa, G., Kogure, M., Yamane, Y., Iwai, Y., Maejima, K., Ueda, K., Masuda, A., Dohmae, N., Field, H. I., Tsunoda, T., Kobayashi, T., Akasu, T., Sugiyama, M., Ohnuma, S., Atomi, Y., Ponder, B. A., Nakamura, Y., and Hamamoto, R. (2012) Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression Cancer Res. 72, 3217-3227
17. Yang, F., Sun, L., Li, Q., Han, X., Lei, L., Zhang, H., and Shang, Y. (2012) SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities EMBO J. 31, 110-123
18. Williams, D. E., Dalisay, D. S., Li, F., Amphlett, J., Maneerat, W., Chavez, M. A., Wang, Y. A., Matainaho, T., Yu, W., Brown, P. J., Arrowsmith, C. H., Vedadi, M., and Andersen, R. J. (2013) Nahuoic acid A produced by a Streptomyces sp. isolated from a marine sediment is a selective SAM-competitive inhibitor of the histone methyltransferase SETD8 Org. Lett. 15, 414-417
19. Valente, S., Lepore, I., DellAversana, C., Tardugno, M., Castellano, S., Sbardella, G., Tomassi, S., Di Maro, S., Novellino, E., Di Santo, R., Costi, R., Altucci, L., and Mai, A. (2012) Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells Biochimie 94, 2308-2313
20. Copeland, R. A., Solomon, M. E., and Richon, V. M. (2009) Protein methyltransferases as a target class for drug discovery Nat. Rev. Drug Discovery 8, 724-732
21. Yuan, Y., Wang, Q., Paulk, J., Kubicek, S., Kemp, M. M., Adams, D. J., Shamji, A. F., Wagner, B. K., and Schreiber, S. L. (2012) A small-molecule probe of the histone methyltransferase G9a induces cellular senescence in pancreatic adenocarcinoma ACS Chem. Biol. 7, 1152-1157
22. Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Majer, C. R., Sneeringer, C. J., Song, J., Johnston, L. D., Scott, M. P., Smith, J. J., Xiao, Y., Jin, L., Kuntz, K. W., Chesworth, R., Moyer, M. P., Bernt, K. M., Tseng, J. C., Kung, A. L., Armstrong, S. A., Copeland, R. A., Richon, V. M., and Pollock, R. M. (2011) Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor Cancer Cell 20, 53-65
23. McCabe, M. T., Ott, H. M., Ganji, G., Korenchuk, S., Thompson, C., Van Aller, G. S., Liu, Y., Graves, A. P., Della Pietra, A., 3rd, Diaz, E., LaFrance, L. V., Mellinger, M., Duquenne, C., Tian, X., Kruger, R. G., McHugh, C. F., Brandt, M., Miller, W. H., Dhanak, D., Verma, S. K., Tummino, P. J., and Creasy, C. L. (2012) EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations Nature 492, 108-112
24. Vedadi, M., Barsyte-Lovejoy, D., Liu, F., Rival-Gervier, S., Allali-Hassani, A., Labrie, V., Wigle, T. J., Dimaggio, P. A., Wasney, G. A., Siarheyeva, A., Dong, A., Tempel, W., Wang, S. C., Chen, X., Chau, I., Mangano, T. J., Huang, X. P., Simpson, C. D., Pattenden, S. G., Norris, J. L., Kireev, D. B., Tripathy, A., Edwards, A., Roth, B. L., Janzen, W. P., Garcia, B. A., Petronis, A., Ellis, J., Brown, P. J., Frye, S. V., Arrowsmith, C. H., and Jin, J. (2011) A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells Nat. Chem. Biol. 7, 566-574
25. Knutson, S. K., Kawano, S., Minoshima, Y., Warholic, N. M., Huang, K. C., Xiao, Y., Kadowaki, T., Uesugi, M., Kuznetsov, G., Kumar, N., Wigle, T. J., Klaus, C. R., Allain, C. J., Raimondi, A., Waters, N. J., Smith, J. J., Porter-Scott, M., Chesworth, R., Moyer, M. P., Copeland, R. A., Richon, V. M., Uenaka, T., Pollock, R., Kuntz, K. W., Yokoi, A., and Keilhack, H. (2014) Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2 -mutant non-Hodgkin lymphoma Mol. Cancer Ther. 13, 842-854
26. Qi, W., Chan, H., Teng, L., Li, L., Chuai, S., Zhang, R., Zeng, J., Li, M., Fan, H., Lin, Y., Gu, J., Ardayfio, O., Zhang, J. H., Yan, X., Fang, J., Mi, Y., Zhang, M., Zhou, T., Feng, G., Chen, Z., Li, G., Yang, T., Zhao, K., Liu, X., Yu, Z., Lu, C. X., Atadja, P., and Li, E. (2012) Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation Proc. Natl. Acad. Sci. U.S.A. 109, 21360-21365
27. Ibanez, G., Shum, D., Blum, G., Bhinder, B., Radu, C., Antczak, C., Luo, M., and Djaballah, H. (2012) A high throughput scintillation proximity imaging assay for protein methyltransferases Comb. Chem. High Throughput Screening 15, 359-371
28. Couture, J. F., Collazo, E., Brunzelle, J. S., and Trievel, R. C. (2005) Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase Genes Dev. 19, 1455-1465
29. Kar, S., Lefterov, I. M., Wang, M., Lazo, J. S., Scott, C. N., Wilcox, C. S., and Carr, B. I. (2003) Binding and inhibition of Cdc25 phosphatases by vitamin K analogues Biochemistry 42, 10490-10497
30. Oda, H., Okamoto, I., Murphy, N., Chu, J., Price, S. M., Shen, M. M., Torres-Padilla, M. E., Heard, E., and Reinberg, D. (2009) Monomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development Mol. Cell. Biol. 29, 2278-2295
31. Pesavento, J. J., Yang, H., Kelleher, N. L., and Mizzen, C. A. (2008) Certain and progressive methylation of histone H4 at lysine 20 during the cell cycle Mol. Cell. Biol. 28, 468-486
32. Zee, B. M., Levin, R. S., Dimaggio, P. A., and Garcia, B. A. (2010) Global turnover of histone post-translational modifications and variants in human cells Epigenet. Chromatin 3, 22
33. Pu, L., Amoscato, A. A., Bier, M. E., and Lazo, J. S. (2002) Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 6-chloro-7-[corrected](2-morpholin-4-ylethylamino)-quinoline-5,8-dione J. Biol. Chem. 277, 46877-46885
34. Brisson, M., Nguyen, T., Wipf, P., Joo, B., Day, B. W., Skoko, J. S., Schreiber, E. M., Foster, C., Bansal, P., and Lazo, J. S. (2005) Redox regulation of Cdc25B by cell-active quinolinediones Mol. Pharmacol. 68, 1810-1820
35. Lazo, J. S., Aslan, D. C., Southwick, E. C., Cooley, K. A., Ducruet, A. P., Joo, B., Vogt, A., and Wipf, P. (2001) Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25 J. Med. Chem. 44, 4042-4049
36. Han, Y., Shen, H., Carr, B. I., Wipf, P., Lazo, J. S., and Pan, S. S. (2004) NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors J. Pharmacol. Exp. Ther. 309, 64-70
37. Liljebris, C., Baranczewski, P., Bjorkstrand, E., Bystrom, S., Lundgren, B., Tjernberg, A., Warolen, M., and James, S. R. (2004) Oxidation of protein tyrosine phosphatases as a pharmaceutical mechanism of action: a study using 4-hydroxy-3,3-dimethyl-2H-benzo[g]indole-2,5(3H)-dione J. Pharmacol. Exp. Ther. 309, 711-719
38. Ryu, C. K., Kang, H. Y., Lee, S. K., Nam, K. A., Hong, C. Y., Ko, W. G., and Lee, B. H. (2000) 5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents Bioorg. Med. Chem. Lett. 10, 461-464
39. Liu, W., Tanasa, B., Tyurina, O. V., Zhou, T. Y., Gassmann, R., Liu, W. T., Ohgi, K. A., Benner, C., Garcia-Bassets, I., Aggarwal, A. K., Desai, A., Dorrestein, P. C., Glass, C. K., and Rosenfeld, M. G. (2010) PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression Nature 466, 508-512
40. Tardat, M., Murr, R., Herceg, Z., Sardet, C., and Julien, E. (2007) PR-Set7-dependent lysine methylation ensures genome replication and stability through S phase J. Cell. Biol. 179, 1413-1426
41. Ma, A., Yu, W., Li, F., Bleich, R. M., Herold, J. M., Butler, K. V., Norris, J. L., Korboukh, V., Tripathy, A., Janzen, W. P., Arrowsmith, C. H., Frye, S. V., Vedadi, M., Brown, P. J., and Jin, J. (2014) Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8 J. Med. Chem. 57, 6822-6833